Safety and Efficacy of the 2.25-mm Sirolimus-Eluting Bx Velocity Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions: the SIRIUS 2.25 Trial

American Journal of Cardiology

Volumn 98, Issue 11, 2006, Pages 1455-1460

  Moses, Jeffrey W ^a   Nikolsky, Eugenia ^a   Mehran, Roxana ^a   Cambier, Patrick A ^b   Bachinsky, William B ^c   Leya, Fred ^d   Kuntz, Richard E ^e   Popma, Jeffrey J ^e   Schleckser, Patricia ^f   Wang, Hong ^f   Cohen, Sidney A ^f   Leon, Martin B ^a  

^a NewYork Presbyterian Hospital   (United States)

^b Morton Plant Hospital   (United States)

^c Harrisburg Hospital   (United States)

^d LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f Department of Medical Affairs and Health Ecomomics Worldwide   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RAPAMYCIN;

ADULT; AGED; ARTERY LESION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE SEVERITY; DRUG ELUTING STENT; FEMALE; HUMAN; IN-STENT RESTENOSIS; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVASCULARIZATION; SAFETY; THROMBOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY RESTENOSIS; CORONARY STENOSIS; DIABETES COMPLICATIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SIROLIMUS; STENTS; TREATMENT OUTCOME;

EID: 33751159826     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2006.06.047     Document Type: Article

References (16)

1. Elezi S., Kastrati A., Neumann F.J., Hadamitzky M., Dirschinger J., and Schomig A. Vessel size and long-term outcome after coronary stent placement. Circulation 98 (1998) 1875-1880
2. Schunkert H., Harrell L., and Palacios I.F. Implications of small reference vessel diameter in patients undergoing percutaneous coronary revascularization. J Am Coll Cardiol 34 (1999) 40-48
3. Kastrati A., Schoming A., Dirshinger J., Mehilli J., Dotzer F., von Welser N., Neumann F.J., and ISAR-SMART Study Investigators. A randomized trial comparing stenting with balloon angioplasty in small vessels in patients with symptomatic coronary artery disease: Intracoronary Stenting or Angioplasty for Restenosis Reduction in Small Arteries. Circulation 102 (2000) 2593-2598
4. Park S.W., Lee C.W., Hong M.K., Kim J.J., Cho G.Y., Nah D.Y., and Park S.J. Randomized comparison of coronary stenting with optimal balloon angioplasty for treatment of lesions in small coronary arteries. Eur Heart J 21 (2000) 1785-1789
5. Doucet S., Schalij M.J., Vrolix M.C., Hilton D., Chenu P., de Bruyne B., Udayachalerm W., Seth A., Bilodeau L., Reiber J.H., et al. Stent placement to prevent restenosis after angioplasty in small coronary arteries. Circulation 104 (2001) 2029-2033
6. Morice M.C., Serruys P.W., Sousa J.E., Fajadet J., Ban Hayashi E., Perin M., Colombo A., Schuler G., Barragan P., Guagliumi G., et al., RAVEL Study Group. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346 (2002) 1773-1780
7. Moses J.W., Leon M.B., Popma J.J., Fitzgerald P.J., Holmes D.R., O'Shaughnessy C., Caputo R.P., Kereiakes D.J., Williams D.O., Teirstein P.S., et al., SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349 (2003) 1315-1323
8. Schofer J., Schluter M., Gershlick A.H., Wijns W., Garcia E., Schampaert E., Breithardt G., and E-SIRIUS Investigators. Sirolimus eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS). Lancet 362 (2003) 1093-1099
9. Schampaert E., Cohen E.A., Schluter M., Reeves F., Traboulsi M., Title L.M., Kuntz R.E., Popma J.J., and C-SIRIUS Investigators. The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS). J Am Coll Cardiol 43 (2004) 1110-1115
10. Fischman D.L., Leon M.B., Baim D.S., Schatz R.A., Savage M.P., Penn I., Detre K., Veltri L., Ricci D., Nobuyoshi M., et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 331 (1994) 496-501
11. Serruys P.W., de Jaegere P., Kiemeneij F., Macaya C., Rutsch W., Heyndrickx G., Emanuelsson H., Marco J., Legrand V., Materne P., et al., Benestent Study Group. A comparison of balloon-expandable implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 331 (1994) 489-495
12. EuroPCR 2004, the Paris Course on Revascularization. SVELTE. Study in patients with de novo coronary artery lesions in small vessels treated with the Cypher stent (2004). http://www.medscape.com/viewprogram/3251 EuroPCR 2004, the Paris Course on Revascularization. Available at: http://www.medscape.com/viewprogram/3251. Accessed on May 25
13. Ardissino D., Cavallini C., Bramucci E., Indolfi C., Marzocchi A., Manari A., Angeloni G., Carosio G., Bonizzoni E., Colusso S., et al., SES-SMART Investigators. Sirolimus-eluting vs uncoated stents for prevention of restenosis in small coronary arteries: a randomized trial. JAMA 292 (2004) 2727-2734
14. Mehilli J., Dibra A., Kastrati A., Pache J., Dirschinger J., and Schomig A. Randomized trial of paclitaxel- and sirolimus-eluting stents in small coronary vessels. Eur Heart J 27 (2006) 260-266
15. Stone G.W., Ellis S.G., Cannon L., Mann J.T., Greenberg J.D., Spriggs D., O'Shaughnessy C.D., DeMaio S., Hall P., Popma J.J., et al., TAXUS V Investigators. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial. JAMA 294 (2005) 1215-1223
16. Morice M.C., Colombo A., Meier B., Serruys P., Tamburino C., Guagliumi G., Sousa E., Stoll H.P., and REALITY Trial Investigators. Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial. JAMA 295 (2006) 895-904